>>
You will find below the elements identified by the HONcode team at a precise date to justify the respect of the 8 ethical principles.
The content of this certificate has been collected and written by the Health On the Net Foundation (HON) and should not be used without previous permission granted by HON. A request for permission can be sent to:
HON.
|
| 1. Information must be authoritative |
Undergraduate School: Allegheny College
Graduate School: University of Cincinnati College of Medicine
Internship: Bethesda Navy Hospital
Residency: Ophthalmology, State University of New York
Board Certification: American Academy of Ophthalmology
Dr. Elliott opened an Ophthalmology practice in 1975 at the Medical Arts Building adjacent to Milford Memorial Hospital. In 1976 he moved into his present location, and shortly thereafter opened a satellite office in Dover. Currently our office has a particular interest in helping patients who have diabetes.
(10 Jul 2011) -
|
2. Presentation of the site
Mission:
|
The primary goal of bemd.com is to provide education and information. There are two main sections. Dr. Brett Elliott intends the first section for his eye patients and the second for applicants who are applying for pilot medical certificates. In both sections there is local information and links to other resources. There are also two smaller sections. The first contains a brief biographic sketch of Dr. Brett Elliott and a list of his recent publications, and the second page is a section on Bioterrorism and Physician Education.
(10 Jul 2011) -
|
| Audience:
|
Dr. Brett Elliott intends the first section for his eye patients and the second for applicants who are applying for pilot medical certificates.
(10 Jul 2011) -
|
| Purpose of the website
|
THE INFORMATION CONTAINED IN THIS SERVICE IS NOT INTENDED OR IMPLIED TO BE A SUBSTITUTE FOR PROFESSIONAL DIAGNOSIS OR TREATMENT.
(10 Jul 2011) -
|
| 3. Confidentiality |
Our E-mail is not encrypted, so it is requested that you do not refer to any personal medical information if you contact our web site.
(10 Jul 2011) -
|
| 4. Information must be documented: Referenced and dated |
http://www.nei.nih.gov/amd/
|
| Only data for one sample are displayed among those selected. |
This data was summarized from the National Eye Institute web site and please visit them for all of their Age-Related Eye Disease Study reports.
(11 Aug 2011) -
|
|
|
This page was last updated on 04/27/11
(10 Jul 2011) -
|
| 5. Justification of claims |
Macugen® (Pegaptanib) and Lucentis® (Ranibizumab) have been approved by the Food and Drug Administration (FDA) for wet macular degeneration and a third drug Avastin® (Bevacizumab) also works well for this condition however it has not been approved by the FDA for ocular use.
(10 Jul 2011) -
|
| 6. User support and adequation |
What about us do you want to comment on?
(10 Jul 2011) -
|
|
|
| 7. Disclosure of funding sources |
This site has no advertising, and its sole sponsor and source of financial support is Brett Elliott, MD, PA.
(10 Jul 2011) -
|
| 8. Advertising policy |
This site has no advertising
(10 Jul 2011) -
|
